background image

Paid Clinical Trials Arizona

Discover 1,559 paid clinical trials in Arizona. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

First-in-human Study of CRB-601-01 to Treat Patients with Advanced Solid Tumor.

Recruiting
PHASE1
PHASE2

Sponsor:

Corbus Pharmaceuticals Inc.

Location:

Tucson AZ, La Jolla CA, Los Angeles CA, Denver COshow 14 more

Code:

NCT06603844

Conditions

Solid Tumor

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

CRB-601 monoclonal antibody

Anti-PD-1 monoclonal antibody

Immune-priming single lesion SBRT

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Recruiting
PHASE2

Sponsor:

Processa Pharmaceuticals

Location:

Tucson AZ, Los Angeles CA, San Antonio TX, Austin TXshow 5 more

Code:

NCT06568692

Conditions

Breast Cancer

TNBC - Triple-Negative Breast Cancer

HER2-negative Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PCS6422 and capecitabine

Capecitabine

A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain

Recruiting
PHASE2

Sponsor:

Eli Lilly and Company

Location:

Tempe AZ, Phoenix AZ, Glendale AZ, Palm Springs CAshow 45 more

Code:

NCT05986292

Conditions

Osteoarthritis, Knee

Diabetic Neuropathic Pain

Chronic Low-back Pain

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LY3016859 ISA

LY3556050 ISA

LY3526318 ISA

LY3857210 ISA

Placebo Oral

Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)

Recruiting
PHASE3

Sponsor:

Alexion Pharmaceuticals, Inc.

Location:

Phoenix AZ, North Las Vegas NV, Loma Linda CA, Orange CAshow 35 more

Code:

NCT06291376

Conditions

Immunoglobulin A Nephropathy

IgAN

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ravulizumab

Placebo

Study of RYZ101 Compared with SOC in Pts W Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

Recruiting
PHASE3

Sponsor:

RayzeBio, Inc.

Location:

Phoenix AZ, Irvine CA, Duarte CA, Los Angeles CAshow 28 more

Code:

NCT05477576

Conditions

GEP-NET

Gastroenteropancreatic Neuroendocrine Tumor

Gastroenteropancreatic Neuroendocrine Tumor Disease

Neuroendocrine Tumors

Carcinoid

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

RYZ101

Everolimus

Sunitinib

Octreotide

Lanreotide

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Recruiting
PHASE1

Sponsor:

AbbVie

Location:

Tucson AZ, San Antonio TX, Dallas TX, Houston TXshow 10 more

Code:

NCT04777994

Conditions

Advanced Solid Tumor Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ABBV-CLS-484

Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI)

Programmed Cell Death-1 (PD-1) Inhibitor

A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation

Recruiting
PHASE3

Sponsor:

Novo Nordisk A/S

Location:

Phoenix AZ, El Paso TX, Loma Linda CA, La Mesa CAshow 160 more

Code:

NCT05636176

Conditions

Heart Failure

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Ziltivekimab

Placebo

Diabetic Foot Ulcer (DFU) Biofilm Infection and Recurrence

Recruiting

Sponsor:

University of Pittsburgh

Location:

Tucson AZ, Cranberry Township PA

Code:

NCT05172089

Conditions

Chronic Wounds

Biofilm Infection

Trans-epidermal Water Loss (TEWL)

Diabetic Foot

Diabetic Foot Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Evaluation of Sonelokimab in Patients with Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Recruiting
PHASE3

Sponsor:

MoonLake Immunotherapeutics AG

Location:

Scottsdale AZ, Upland CA, Lubbock TX, Colleyville TXshow 5 more

Code:

NCT06641089

Conditions

Arthritis, Psoriatic

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Sonelokimab

Placebo

Risankizumab

Substudy 06C: A Study of Sacituzumab Tirumotecan (MK-2870) With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)

Recruiting
PHASE1
PHASE2

Sponsor:

Merck Sharp & Dohme LLC

Location:

Tucson AZ, Houston TX, Louisville KY, Grand Rapids MIshow 3 more

Code:

NCT06469944

Conditions

Gastroesophageal Junction

Gastroesophageal Adenocarcinoma

Esophageal Neoplasms

Esophageal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Sacituzumab Tirumotecan (sac-TMT)

Capecitabine

Leucovorin

Levoleucovorin

Popular cities in Arizona

With a diverse healthcare network and renowned medical research institutions, Arizona is a key player in clinical research. Leading clinical research organizations such as the Mayo Clinic in Phoenix, Banner Health, University of Arizona Health Sciences, and the Translational Genomics Research Institute (TGen) are driving medical research and innovation advancements. These institutions are at the forefront of clinical studies, contributing significantly to cutting-edge treatments and healthcare advancements across the state.

Why choose Arizona for clinical trials?

Common conditions studied in Arizona

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Arizona